Wang X, Zhou Y, Zhang S, Farrar C, et al. Targeting mTORC2-Dependent AKT/FOXO1/RNF125 signaling exploits a therapeutic vulnerability in c-MET-activated and beta-catenin-mutated hepatocellular carcinoma. Hepatology 2025 Dec 2. doi: 10.1097/HEP.0000000000001637.
PMID: 41329937